Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma

Austin D. Newsama Medical Scientist Training Program, University of Miami Miller School of Medicine, Miami, FL, USA;b Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL, USA;c Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USAView further author information

Caroline A. Coughlina Medical Scientist Training Program, University of Miami Miller School of Medicine, Miami, FL, USA;b Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami Miller School of Medicine, Miami, FL, USA;c Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USAView further author information

Asaad Trabolsic Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA;d Hematology-Oncology Fellowship Training Program, Jackson Memorial Hospital, Miami, FL, USAView further author information

Jonathan H. Schatzc Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA;e Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USACorrespondence[email protected]
View further author information

Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date